Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-01

Clinical Trial Update: An Efficacy Study to Evaluate Alfuzosin to Treat Men With Erectile Dysfunction and Mild Lower Urinary Tract Symptoms [Phase 3]

View source ↗

Summary

Phase 3 efficacy study evaluating alfuzosin for men with erectile dysfunction and mild lower urinary tract symptoms has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alfuzosin (alfuzosin)

Snippet

Sponsor: Chesapeake Urology Research Associates | Conditions: Erectile Dysfunction, Lower Urinary Tract Symptoms | Phase 3 | Status: COMPLETED | Results posted: 2016-08-01